Home/Pipeline/PCS499

PCS499

Ulcerative Necrobiosis Lipoidica

Phase 2bActive (Seeking Partnership)

Key Facts

Indication
Ulcerative Necrobiosis Lipoidica
Phase
Phase 2b
Status
Active (Seeking Partnership)
Company

About Processa Pharmaceuticals

Processa Pharmaceuticals is a clinical-stage biopharma focused on improving survival and quality of life for patients with life-threatening or life-compromising chronic diseases. Its core strategy involves applying a proprietary regulatory science methodology to de-risk and accelerate the development of acquired or in-licensed clinical-stage drug candidates, aiming for higher probability of success and capital efficiency. The leadership team, with a collective history of over 30 years, claims involvement in the approval of more than 30 FDA drugs, forming the foundation of its patient-centric development model.

View full company profile